Exchange Announcement • 07 Mar 2025 10:07
Exchange Announcement • 07 Mar 2025 09:54
Exchange Announcement • 06 Mar 2025 07:16
Exchange Announcement • 26 Feb 2025 06:36
Exchange Announcement • 19 Feb 2025 05:54
ENTITY
SK Biopharmaceuticals (326030 KS)
SK Biopharmaceuticals (326030 KS)
134
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
morex